Monday, August 10, 2015
OncoMed Pharmaceuticals Announces Second Quarter 2015 Financial Results and Updates Demcizumab Phase 1b Non-Small Cell Lung Cancer Survival Data
… first-line advanced stage non-small cell lung cancer reveals impressive long term survival … with first-line advanced non-small cell lung cancer (NSCLC) and pancreatic cancer and … tarextumab, including in small cell lung cancer patients with tumors positive for …
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment